301015 百洋醫藥
按盤價 
23.600 +0.600 (+2.609%)
23.600 +0.600 (+2.609%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 19.620 | 26.267 | 27.425 | 22.722 | 23.236 |
| 總資產報酬率 ROA (%) | 6.480 | 10.223 | 12.440 | 10.518 | 9.801 |
| 投入資產回報率 ROIC (%) | 8.399 | 13.686 | 15.948 | 12.901 | 12.402 | 邊際利潤分析 |
| 銷售毛利率 (%) | 37.383 | 35.503 | 33.295 | 27.761 | 25.127 |
| 營業利潤率 (%) | 12.555 | 12.079 | 12.641 | 8.979 | 7.963 |
| 息稅前利潤/營業總收入 (%) | 13.749 | 12.820 | 13.246 | 9.547 | 8.888 |
| 淨利潤/營業總收入 (%) | 9.963 | 9.476 | 9.335 | 6.523 | 5.885 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 95.315 | 95.706 | 97.201 | 101.354 | 97.099 |
| 價值變動淨收益/利潤總額(%) | 9.774 | 6.303 | 4.398 | -1.327 | 1.729 |
| 營業外收支淨額/利潤總額(%) | -1.609 | -1.149 | -1.519 | -0.854 | 0.696 | 償債能力分析 |
| 流動比率 (X) | 1.552 | 1.569 | 2.140 | 1.635 | 1.704 |
| 速動比率 (X) | 1.316 | 1.284 | 1.780 | 1.386 | 1.444 |
| 資產負債率 (%) | 63.594 | 63.379 | 51.391 | 54.688 | 52.767 |
| 帶息債務/全部投入資本 (%) | 56.799 | 52.596 | 37.059 | 40.604 | 41.420 |
| 股東權益/帶息債務 (%) | 72.268 | 85.200 | 162.285 | 137.491 | 139.615 |
| 股東權益/負債合計 (%) | 51.402 | 52.683 | 87.660 | 83.671 | 88.824 |
| 利息保障倍數 (X) | 9.871 | 14.594 | 16.668 | 14.817 | 10.218 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 82.953 | 90.461 | 91.822 | 93.134 | 87.171 |
| 存貨周轉天數 (天) | 66.622 | 61.697 | 49.412 | 42.270 | 42.077 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 31/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
